Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,795
Total Claims
$673K
Drug Cost
513
Beneficiaries
$1,311
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+78%
Opioid rate vs peers
4.0% vs 2.2% avg
-7%
Cost per patient vs peers
$1,311 vs $1,411 avg
+5%
Brand preference vs peers
11.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.0%
Opioid Rate
351
Opioid Claims
$11K
Opioid Cost
9.7%
Long-Acting Rate
Brand vs Generic
Brand: 973 claims · $518K
Generic: 7,745 claims · $152K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 55 | $68K |
| Sitagliptin Phosphate | 66 | $61K |
| Apixaban | 34 | $43K |
| Empagliflozin | 17 | $32K |
| Fluticasone/Umeclidin/Vilanter | 41 | $28K |
| Insulin Lispro Protamin/Lispro | 32 | $22K |
| Rivaroxaban | 14 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $16K |
| Linaclotide | 15 | $16K |
| Insulin Aspart Prot/Insuln Asp | 19 | $15K |
| Pitavastatin Calcium | 16 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $9,062 |
| Atorvastatin Calcium | 584 | $8,288 |
| Fluticasone Propion/Salmeterol | 13 | $7,428 |
| Insulin Nph Hum/Reg Insulin Hm | 16 | $7,376 |
Prescribing Profile
Patient Profile
75
Avg Age
47%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About